Home  »  Finance   »  Attention Investors: What’s Really Going On With...

Attention Investors: What’s Really Going On With Smith & Nephew plc (NYSE: SNN)

The trading price of Smith & Nephew plc (NYSE:SNN) floating lower at last check on Wednesday, May 24, closing at $30.16, -2.54% lower than its previous close.

Traders who pay close attention to intraday price movement should know that it has been fluctuating between $30.93 and $31.7158. The company’s P/E ratio in the trailing 12-month period was 60.79, while its 5Y monthly beta was 0.37. In examining the 52-week price action we see that the stock hit a 52-week high of $33.08 and a 52-week low of $21.77. Over the past month, the stock has lost -4.30% in value.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


Smith & Nephew plc, whose market valuation is $13.65 billion at the time of this writing. The dividend yield on the company stock is 3.92%, while its Forward Dividend ratio is 1.21. Investors’ optimism about the company’s current quarter earnings report is understandable.

A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Smith & Nephew plc No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest SNN has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.

Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned SNN a recommendation rating is 17. Out of them, 6 rate it a Hold, while 7 recommend Buy, whereas 2 assign an Overweight rating. 0 analyst(s) have tagged Smith & Nephew plc (SNN) as Underweight, while 2 advise Sell. Analysts have rated the stock Overweight, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.

If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 13.21, which symbolizes a positive outlook. A quick review shows that SNN’s price is currently -5.89% off the SMA20 and -0.35% off the SMA50. The RSI metric on the 14-day chart is currently showing 36.28, and weekly volatility stands at 1.32%. When measured over the past 30 days, the indicator reaches 1.10%. Smith & Nephew plc (NYSE:SNN)’s beta value is currently sitting at 0.60, while the Average True Range indicator is currently displaying 0.49.

To see how Smith & Nephew plc stock has been performing today in comparison to its peers in the industry, here are the numbers: SNN stock’s performance was -2.54% at last check in today’s session, and -7.30% in the past year, while Johnson & Johnson (JNJ) has been trading -0.02% in recent session and positioned -12.63% lower than it was a year ago. Another comparable company Boston Scientific Corporation (BSX) saw its stock trading 1.07% higher in today’s session but was up 30.48% in a year. Furthermore, Zimmer Biomet Holdings Inc. (ZBH) showed a decrease of -0.85% today while its price kept inclining at 6.94% over the past year. Smith & Nephew plc has a P/E ratio of 60.79, compared to Johnson & Johnson’s 32.81 and Boston Scientific Corporation’s 87.88. Also during today’s trading, the S&P 500 Index has plunged -0.88%, while the Dow Jones Industrial also saw a negative session, down -0.71% today.

An evaluation of the daily trading volume of Smith & Nephew plc (NYSE:SNN) indicates that the 3-month average is 928.60K. However, this figure has increased over the past 10 days to an average of 0.74 million.

Currently, records show that 436.39 million of the company’s shares remain outstanding. The insiders hold 0.60% of outstanding shares, whereas institutions hold 9.80%. The stats also highlight that short interest as of Apr 27, 2023, stood at 1.04 million shares, resulting in a short ratio of 1.08 at that time. From this, we can conclude that short interest is 0.24% of the company’s total outstanding shares. It is noteworthy that short shares in April were down slightly from the previous month’s figure, which was 2.36 million. However, since the stock’s price has seen 12.14% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.

Leave a Comment

Your email address will not be published. Required fields are marked *